Vivlodex

Product NDC: 42211-206
11-digit product format: 422110206
Labeler code: 42211
Product ID: 42211-206_56e0f811-6718-49ce-b054-c6ffd07545a0
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: meloxicam
Dosage form: CAPSULE
Route: ORAL
Labeler: Iroko Pharmaceuticals, LLC
Application: NDA207233
Marketing category: NDA
Marketing start: 2015-10-31
Marketing end: 0000-00-00
Substance: MELOXICAM
Active strength: 10 mg/1
Pharmacologic classes: Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	42211-206		I	Inactivated by FDA	2026-08-03
excluded package	package	42211-206	42211-206-23	I	Inactivated by FDA	2026-08-03
excluded package	package	42211-206	42211-206-29	I	Inactivated by FDA	2026-08-03
excluded package	package	42211-206	42211-206-41	I	Inactivated by FDA	2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 76 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	42211-206-41	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	42211-206-23	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	42211-206-29	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	42211-206-41	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	42211-206-23	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	42211-206-29	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	42211-206-41	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	42211-206-23	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	42211-206-29	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	42211-206-41	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	42211-206-23	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	42211-206-29	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	42211-206-41	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	42211-206-23	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	42211-206-29	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	42211-206-41	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	42211-206-23	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	42211-206-29	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	42211-206-41	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	42211-206-23	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	42211-206-29	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	42211-206-41	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	42211-206-23	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	42211-206-29	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	42211-206-41	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	42211-206-23	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	42211-206-29	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	42211-206-41	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	42211-206-23	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	42211-206-29	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	42211-206-41	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	42211-206-23	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	42211-206-29	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	42211-206-41	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	42211-206-23	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	42211-206-29	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	42211-206-41	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	42211-206-23	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	42211-206-29	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	42211-206-41	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	42211-206-23	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	42211-206-29	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	42211-206-41	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	42211-206-23	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	42211-206-29	`1332a3947898…`	`d4bfe170f9cd…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N207233-001	VIVLODEX	MELOXICAM	5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL		RLD	2015-10-22
N207233-002	VIVLODEX	MELOXICAM	10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL		RLD	2015-10-22

Orange Book patents#

Current patent rows page 1 of 1 · 8 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N207233-001	9526734	2033-03-31		Drug product	2016-12-30
N207233-001	9649318	2035-03-31		Drug product	2017-05-16
N207233-001	9808468	2035-03-31	U-2160		2017-11-22
N207233-001	9808468	2035-03-31	U-2165		2017-11-22
N207233-002	9526734	2033-03-31		Drug product	2016-12-30
N207233-002	9649318	2035-03-31		Drug product	2017-05-16
N207233-002	9808468	2035-03-31	U-2160		2017-11-22
N207233-002	9808468	2035-03-31	U-2165		2017-11-22

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N207233-001	VIVLODEX	5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N207233-002	VIVLODEX	10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N207233-001	VIVLODEX	5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N207233-002	VIVLODEX	10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N207233-001	VIVLODEX	5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N207233-002	VIVLODEX	10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N207233-001	VIVLODEX	5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N207233-002	VIVLODEX	10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N207233-001	VIVLODEX	5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N207233-002	VIVLODEX	10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N207233-001	VIVLODEX	5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N207233-002	VIVLODEX	10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N207233-001	VIVLODEX	5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N207233-002	VIVLODEX	10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N207233-001	VIVLODEX	5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N207233-002	VIVLODEX	10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N207233-001	VIVLODEX	5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N207233-002	VIVLODEX	10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N207233-001	VIVLODEX	5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N207233-002	VIVLODEX	10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N207233-001	VIVLODEX	5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N207233-002	VIVLODEX	10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N207233-001	VIVLODEX	5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N207233-002	VIVLODEX	10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N207233-001	VIVLODEX	5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N207233-002	VIVLODEX	10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N207233-001	VIVLODEX	5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N207233-002	VIVLODEX	10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N207233-001	VIVLODEX	5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N207233-002	VIVLODEX	10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N207233-001	VIVLODEX	5MG	CAPSULE / ORAL	RLD	2015-10-22	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N207233-002	VIVLODEX	10MG	CAPSULE / ORAL	RLD	2015-10-22	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N207233-001	VIVLODEX	5MG	CAPSULE / ORAL	RLD	2015-10-22	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N207233-002	VIVLODEX	10MG	CAPSULE / ORAL	RLD	2015-10-22	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N207233-001	VIVLODEX	5MG	CAPSULE / ORAL	RLD	2015-10-22	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N207233-002	VIVLODEX	10MG	CAPSULE / ORAL	RLD, RS	2015-10-22	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N207233-001	VIVLODEX	5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N207233-002	VIVLODEX	10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	RLD	2015-10-22	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N207233-001	VIVLODEX	5MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	CAPSULE / ORAL	RLD	2015-10-22	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N207233-002	VIVLODEX	10MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	CAPSULE / ORAL	RLD	2015-10-22	`782e0a99824c…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2020-11-12 02:37 UTC	2020-11	N207233-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N207233-002	AB	1	`c0c555d07b60…`

Observed Orange Book patent history#

Patent history page 1 of 9 · 328 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N207233-001	9526734	2033-03-31		Drug product	2016-12-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N207233-001	9649318	2035-03-31		Drug product	2017-05-16	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N207233-001	9808468	2035-03-31	U-2165		2017-11-22	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N207233-001	9808468	2035-03-31	U-2160		2017-11-22	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N207233-002	9526734	2033-03-31		Drug product	2016-12-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N207233-002	9649318	2035-03-31		Drug product	2017-05-16	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N207233-002	9808468	2035-03-31	U-2160		2017-11-22	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N207233-002	9808468	2035-03-31	U-2165		2017-11-22	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N207233-001	9526734	2033-03-31		Drug product	2016-12-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N207233-001	9649318	2035-03-31		Drug product	2017-05-16	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N207233-001	9808468	2035-03-31	U-2165		2017-11-22	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N207233-001	9808468	2035-03-31	U-2160		2017-11-22	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N207233-002	9526734	2033-03-31		Drug product	2016-12-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N207233-002	9649318	2035-03-31		Drug product	2017-05-16	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N207233-002	9808468	2035-03-31	U-2160		2017-11-22	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N207233-002	9808468	2035-03-31	U-2165		2017-11-22	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N207233-001	9526734	2033-03-31		Drug product	2016-12-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N207233-001	9649318	2035-03-31		Drug product	2017-05-16	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N207233-001	9808468	2035-03-31	U-2165		2017-11-22	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N207233-001	9808468	2035-03-31	U-2160		2017-11-22	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N207233-002	9526734	2033-03-31		Drug product	2016-12-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N207233-002	9649318	2035-03-31		Drug product	2017-05-16	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N207233-002	9808468	2035-03-31	U-2160		2017-11-22	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N207233-002	9808468	2035-03-31	U-2165		2017-11-22	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N207233-001	9526734	2033-03-31		Drug product	2016-12-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N207233-001	9649318	2035-03-31		Drug product	2017-05-16	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N207233-001	9808468	2035-03-31	U-2165		2017-11-22	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N207233-001	9808468	2035-03-31	U-2160		2017-11-22	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N207233-002	9526734	2033-03-31		Drug product	2016-12-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N207233-002	9649318	2035-03-31		Drug product	2017-05-16	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N207233-002	9808468	2035-03-31	U-2160		2017-11-22	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N207233-002	9808468	2035-03-31	U-2165		2017-11-22	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N207233-001	9526734	2033-03-31		Drug product	2016-12-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N207233-001	9649318	2035-03-31		Drug product	2017-05-16	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N207233-001	9808468	2035-03-31	U-2165		2017-11-22	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N207233-001	9808468	2035-03-31	U-2160		2017-11-22	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N207233-002	9526734	2033-03-31		Drug product	2016-12-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N207233-002	9649318	2035-03-31		Drug product	2017-05-16	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N207233-002	9808468	2035-03-31	U-2160		2017-11-22	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N207233-002	9808468	2035-03-31	U-2165		2017-11-22	`b8a1b40f171c…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
bdef11ce-16e2-4690-96a3-597bcf5cc738	Product name	1	20260130
f2791553-0b76-42f4-8d49-af3eda072bfb	Product name	1	20251117
e3a99641-4540-4894-9108-00cab3c57b7e	Product name	1	20211207
3e9b4ed6-844c-4725-9d19-cceb5c823572	Product name	2	20210903
b21a682e-c765-4e26-9bb2-dbb8c7b38ef7	Product name	1	20200623
a428d1db-64d7-4fc3-8d13-832b1e84b683	Product name	1	20190201
96649a58-aac8-401c-be00-450b4335f7e7	Product name	1	20161116
f0761cb7-8207-3a19-2ca3-ecbb559b04e1	Product name	2	20161116

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
42211-206-23	2021-01-29	C162847	48780-1	ba0f9c33-3a38-a910-e053-dadaa90a0b85	These highlights do not include all the information needed to use VIVLODEX™ safely and effectively. See full prescribing information for VIVLODEX. VIVLODEX (meloxicam) capsules, for oral use Initial U.S. Approval: 2000
42211-206-29	2021-01-29	C162847	48780-1	ba0f9c33-3a38-a910-e053-dadaa90a0b85	These highlights do not include all the information needed to use VIVLODEX™ safely and effectively. See full prescribing information for VIVLODEX. VIVLODEX (meloxicam) capsules, for oral use Initial U.S. Approval: 2000
42211-206-41	2021-01-29	C162847	48780-1	ba0f9c33-3a38-a910-e053-dadaa90a0b85	These highlights do not include all the information needed to use VIVLODEX™ safely and effectively. See full prescribing information for VIVLODEX. VIVLODEX (meloxicam) capsules, for oral use Initial U.S. Approval: 2000

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
42211-206-23	Vivlodex	30 in 1 BOTTLE	CAPSULE	30	4
42211-206-29	Vivlodex	90 in 1 BOTTLE	CAPSULE	90	4
42211-206-41	Vivlodex	1 in 1 BLISTER PACK	CAPSULE	1	4

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
42211-206-23	EA - Each	42211-206	e1e2cf52-3f2f-4833-8ccf-eafff065faf8	1	2015-12-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
meloxicam	ACTIVE INGREDIENT	VG2QF83CGL	VIVLODEX (MELOXICAM) CAPSULE [IROKO PHARMACEUTICALS, LLC]	3
meloxicam	ACTIVE MOIETY	VG2QF83CGL	VIVLODEX (MELOXICAM) CAPSULE [IROKO PHARMACEUTICALS, LLC]	3
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	VIVLODEX (MELOXICAM) CAPSULE [IROKO PHARMACEUTICALS, LLC]	3
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	VIVLODEX (MELOXICAM) CAPSULE [IROKO PHARMACEUTICALS, LLC]	3
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	VIVLODEX (MELOXICAM) CAPSULE [IROKO PHARMACEUTICALS, LLC]	3
FD&C Red NO. 40	INACTIVE INGREDIENT	WZB9127XOA	VIVLODEX (MELOXICAM) CAPSULE [IROKO PHARMACEUTICALS, LLC]	3
FD&C yellow NO. 6	INACTIVE INGREDIENT	H77VEI93A8	VIVLODEX (MELOXICAM) CAPSULE [IROKO PHARMACEUTICALS, LLC]	3
GELATIN	INACTIVE INGREDIENT	2G86QN327L	VIVLODEX (MELOXICAM) CAPSULE [IROKO PHARMACEUTICALS, LLC]	3
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	VIVLODEX (MELOXICAM) CAPSULE [IROKO PHARMACEUTICALS, LLC]	3
PIGMENT RED 5	INACTIVE INGREDIENT	91OZU993LX	VIVLODEX (MELOXICAM) CAPSULE [IROKO PHARMACEUTICALS, LLC]	3
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	VIVLODEX (MELOXICAM) CAPSULE [IROKO PHARMACEUTICALS, LLC]	3
SODIUM STEARYL FUMARATE	INACTIVE INGREDIENT	7CV7WJK4UI	VIVLODEX (MELOXICAM) CAPSULE [IROKO PHARMACEUTICALS, LLC]	3
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	VIVLODEX (MELOXICAM) CAPSULE [IROKO PHARMACEUTICALS, LLC]	3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
42211-206	VIVLODEX (MELOXICAM) CAPSULE [IROKO PHARMACEUTICALS, LLC]	4	Legacy NDC, 3 package rows	20190411_fcfd6c24-98d0-4b7b-8336-936899ef61de.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
VG2QF83CGL	MELOXICAM	71125-38-7	MELOXICAM

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1722357	meloxicam 10 MG Oral Capsule	PSN	fcfd6c24-98d0-4b7b-8336-936899ef61de	4
1722349	meloxicam 5 MG Oral Capsule	PSN	fcfd6c24-98d0-4b7b-8336-936899ef61de	4
1722359	Vivlodex 10 MG Oral Capsule	PSN	fcfd6c24-98d0-4b7b-8336-936899ef61de	4
1722355	Vivlodex 5 MG Oral Capsule	PSN	fcfd6c24-98d0-4b7b-8336-936899ef61de	4
1722359	meloxicam 10 MG Oral Capsule [Vivlodex]	SBD	fcfd6c24-98d0-4b7b-8336-936899ef61de	4
1722355	meloxicam 5 MG Oral Capsule [Vivlodex]	SBD	fcfd6c24-98d0-4b7b-8336-936899ef61de	4
1722357	meloxicam 10 MG Oral Capsule	SCD	fcfd6c24-98d0-4b7b-8336-936899ef61de	4
1722349	meloxicam 5 MG Oral Capsule	SCD	fcfd6c24-98d0-4b7b-8336-936899ef61de	4
1722359	Vivlodex 10 MG Oral Capsule	SY	fcfd6c24-98d0-4b7b-8336-936899ef61de	4
1722355	Vivlodex 5 MG Oral Capsule	SY	fcfd6c24-98d0-4b7b-8336-936899ef61de	4

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
42211-206-23	42211020623	30 in 1 BOTTLE	Historical
42211-206-29	42211020629	90 in 1 BOTTLE	Historical
42211-206-41	42211020641	1 in 1 BLISTER PACK	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Vivlodex	Iroko Pharmaceuticals, LLC \| Catalent CTS, LLC \| Neolpharma, Inc.	2019-04-08	HUMAN PRESCRIPTION DRUG LABEL	4